Document is current

Article History

Received: 21 April 2024

Accepted: 5 October 2024

First Online: 23 October 2024

Declarations

:

: C.M. reports research Funding from Eisai, Yakult Honsha, Ono Pharmaceutical, Taiho Pharmaceutical, J-Pharma, AstraZeneca, Merck biopharma, Daiichi Sankyo, Boehringer Ingelheim, and honoraria from Novartis, Yakult Honsha, Teijin Pahrma, Eisai, MSD, AstraZeneka, SERVIER, Boehringer Ingelheim, Taiho. J.M.reports Employment/Leadership position/Advisory role from Phizer and honoraria from Chugai Pharmaceutical, Taiho Pharmaceutical, AstraZeneca. S.K. reports research funding from Bayer, Boston Scientific, Chugai Pharmaceutical, Eisai, Eli Lilly Japan, Takeda, Taiho Pharmaceutical, Yakult Honsha. H.I reports fees for promotional materials from Medico’s Hirata, and honoraria from Boston Scientific, Kaneka Medix, Medico’s Hirata, SB KAWASUMI LABORATORIES, AstraZeneca. H.K. reports grants from BMS K.K., ONO Pharmaceutical, Eli Lilly Japan, MSD K.K., and Daiichi Sankyo, and honoraria from Bristol-Myers Squibb, Eli Lilly Japan, MSD K.K., Ono Pharmaceutical, Chugai Pharmaceutical, Daiichi Sankyo, Merck Biopharma, Takeda Pharmaceutical, Yakult Pharmaceutical Industry, Teijin Pharma, Taiho Pharmaceutical, Otsuka Pharmaceutical, Nippon Kayaku, and GlaxoSmithKline. M.I. reports Research Funding from AstraZeneca, Boehringer Ingelheim GmbH, Eisai, J-pharma, Merk biopharma, Ono Pharmaceutical, Eli Lilly Japan, and honoraria from AstraZeneca, Guardant Health Japan, Incyte, Taiho Pharmaceutical. N.M. reports research funding from Novartis, MSD, Incyte, Ono Pharmaceutical, Seagen, Pfizer, Boehringer Ingelheim, AstraZeneca and honoraria from Yakult Honsha, AstraZeneca, Novartis, FUJIFILM Toyama Chemical, MSD, Taiho Pharmaceutical, Boehringer Ingelheim. F.J. reports Research funding from MSD, J-Pharma, Delta-fly-Phrama, Taiho Pharmaceutical, Eisai, Ono Pharmaceutical, Chugai Pharmaceutical, Daiichi Sankyo, Takeda Pharmaceutical, Yakult Honsha and honoraria from Ono Pharmaceutical, Chugai Pharmaceutical, Eisai, Incyte Biosiciences, Eli Lilly Japan, Fuji Film, AstraZeneca, Yakult Honsha. U.M. reports research funding from Taiho Pharmaceutical, AstraZeneca, MSD, Nihon Servier, Ono Pharmaceutical, Incyte Biosciences Japan GK, Chugai Pharmaceutical, Boehringer Ingelheim GmbH, J-pharma, Eisai, Novartis Pharma K.K, Astellas, J-pharma, Delta-fly-Phrama, Novocure GmbH, and Chiome Bioscience Inc. and honoraria from Taiho Pharmaceutical, AstraZeneca, K.K, Yakult Honsha, MSD K.K, Nihon Servier, Ono Pharmaceutical, Incyte Biosciences Japan GK, Chugai Pharmaceutical, Boehringer Ingelheim GmbH, J-pharma, Daiichi Sankyo, Eisai, Takeda Pharmaceutical, Novartis Pharma K.K.